S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease

Nephron - Clinical Practice

Volumn 123, Issue 3-4, 2013, Pages 202-208

  Hara, Masaki ^a,b   Ando, Minoru ^a,b   Morito, Taku ^a,b   Nokiba, Hirohiko ^a,b   Iwasa, Yuko ^a,b   Tsuchiya, Ken ^b   Nitta, Kosaku ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Diabetes mellitus; EN RAGE; Real time RT PCR

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; MESSENGER RNA; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM BINDING PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; S100A12 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; HUMAN; LEUKOCYTE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; S100A12 GENE; STAGING; UREMIA; ANTIHYPERTENSIVE THERAPY; BLOOD SAMPLING; CONFIDENCE INTERVAL; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN CELL; HYPERTENSION; MIDDLE AGED; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEINURIA; QUANTITATIVE ANALYSIS; RENAL REPLACEMENT THERAPY; SERUM;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER; S100 PROTEINS;

EID: 84880966338     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000353808     Document Type: Article

References (25)

1. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637-668.
2. Hofmann MA, Drury S, Fu C, et al: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97: 889-901.
3. Burke AP, Kolodgie FD, Zieske A, et al: Morphologic findings of coronary atheroscrelotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 2004; 24: 1266-1271.
4. Hofmann M, Wilk J, Heydemann A, et al: S100A12 mediates aortic wall remodeling and aortic aneurysm. Cir Res 2010; 106: 145-154.
5. Kosaki A, Hasegawa T, Kimura T, et al: Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 5423-5428.
6. Shiotsu Y, Mori Y, Nishimura M, et al: Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 718-723.
7. Mori Y, Kosaki A, Kishimoto N, et al: Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis. Am J Nephrol 2009; 29: 18-24.
8. Nakashima A, Carrero JJ, Qureshi AR, et al: Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE igand (ENRAGE, S100A12) on mortality in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 2213-2219.
9. Uchiyama-Tanaka Y, Mori Y, Kosaki A, et al: Plasma S100A12 concentrations in peritoneal dialysis patients and subclinical chronic inflammatory disease. Ther Apher Dial 2008; 12: 28-32.
10. Kim JK, Park B, Lee MJ, et al: Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis 2012; 220: 208-214.
11. Matsuo S, Imai E, Horio M, et al: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
12. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(suppl 1): S1-S26.
13. Rainen L, Oelmueller S, Jurgensen R, et al: Stabilization of mRNA expression in whole blood samples. Clin Chem 2002; 48: 1883-1890.
14. Espitia CM, Zhao W, Saldarriaga O, et al: Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis. BMC Immunol 2010; 11: 31.
15. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 -δ δCt Method. Methods 2001; 25: 402-408.
16. Schmittgen TD, Livak KJ: Analyzing realtime PCR data by the comparative C T method. Nat Proc 2008; 3: 1101-1108.
17. Hanford LE, Enghild JJ, Valnickova Z, et al: Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 2004; 279: 50019-50024.
18. Hasegawa T, Kosaki A, Kimura T, et al: The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages. Atherosclerosis 2003; 171: 211-218.
19. Goyette J, Yan WX, Yaman E, et al: Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture. J Immunol 2009; 183: 593-603.
20. Matsuoka E, Mori Y, Shiots Y, Kosaki A: http://www.asn-online.org/ educationandmeetings/kidneyweek/archives/KW11Abstracts.pdf. THPO-127, 139A (accessed April, 2012).
21. Fink HA, Ishani A, Taylor BC, et al: Screening for monitoring and treatment of chronic kidney disease stages 1 to 3: a systematic review for the US Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2012; 156: 570-581.
22. Ruggenenti P, Cravedi P, Remuzzi G: The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nat Rev Nephrol 2010; 6: 319-330.
23. Raizada V, Hillerson D, Amaram JS, Skipper B: Angiotensin II-mediated left ventricular abnormalities in chronic kidney disease. J Investig Med 2012; 60: 785-791.
24. Kalousova M, Hodkova M, Kazderova M, et al: Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis 2006; 47: 406-411.
25. Basta G, Leonardis D, Mallamaci F, et al: Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. Kidney Int 2010; 77: 225-231.